Ansamycin antibiotic

This page covers all Ansamycin antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial RNA polymerase.

Targets

Bacterial RNA polymerase

Phase 3 pipeline (1)

• Rifamycin SV MMX · RedHill Biopharma Limited · Gastroenterology / Infectious Disease
  Rifamycin SV MMX is a modified-release antibiotic that targets bacterial RNA polymerase to inhibit bacterial protein synthesis, with enhanced delivery to the colon.

Patent intelligence

• ansamycin antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates